 FOSTER CITY, Calif.-- BUSINESS WIRE --Mirum Pharmaceuticals, Inc. Nasdaq: MIRM, a biopharmaceutical company focused on the identification, acquisition, development and commercialization of novel therapies for debilitating rare and orphan diseases, today announced that it will participate in the following upcoming investor conferences: 